Early-life exposure to lipopolysaccharide reduces the severity of experimental autoimmune encephalomyelitis in adulthood and correlated with increased urine corticosterone and apoptotic CD4+ T cells

Neuroscience

Volumn 193, Issue , 2011, Pages 283-290

  Wang, Z W ^a,b   Wang, P ^a   Lin, F H ^a   Li, X L ^a   Li, X F ^c   O'Byrne, K Thomas ^c   Hou, S T ^a,d   Zheng, R Y ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b SHAOXING PEOPLE S HOSPITAL   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Corticosterone; Experimental autoimmune encephalomyelitis; Immune regulation; Lipopolysaccharide; Multiple sclerosis; Neuroprotection

Indexed keywords

CORTICOSTERONE; LIPOPOLYSACCHARIDE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EXPOSURE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; UPREGULATION; URINALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANNEXIN A5; ANTIGENS, CD; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CORTICOSTERONE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FREUND'S ADJUVANT; HISTOCOMPATIBILITY ANTIGENS CLASS II; LIPOPOLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SPINAL CORD; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 80052461664     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.047     Document Type: Article

References (31)

1. Brennan F.X., Ottenweller J.E., Seifu Y., Zhu G., Servatius R.J. Persistent stress-induced elevations of urinary corticosterone in rats. Physiol Behav 2000, 71:441-446.
2. Choi J., Fauce S.R., Effros R.B. Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav Immun 2008, 22:600-605.
3. Claustrat B., Valatx J.L., Harthé C., Brun J. Effect of constant light on prolactin and corticosterone rhythms evaluated using a noninvasive urine sampling protocol in the rat. Horm Metab Res 2008, 40:398-403.
4. Ellestad K.K., Tsutsui S., Noorbakhsh F., Warren K.G., Yong V.W., Pittman Q.J., Power C. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol 2009, 183:298-309.
5. Harbuz M. Neuroendocrine function and chronic inflammatory stress. Exp Physiol 2002, 87:519-525.
6. Herold M.J., McPherson K.G., Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006, 63:60-72.
7. Hou S.T., Jiang S.X., Desbois A., Huang D., Kelly J., Tessier L., Karchewski L., Kappler J. Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J Neurosci 2006, 26:2241-2249.
8. Hou S.T., Keklikian A., Slinn J., O'Hare M., Jiang S.X., Aylsworth A. Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery. Biochem Biophys Res Commun 2008, 367:109-115.
9. Jaworek J., Leja-Szpak A., Nawrot-Porabka K., Bonior J., Szklarczyk J., Kot M., Konturek S.J., Tomaszewska R., Pawlik W.W. Effect of neonatal endotoxemia on the pancreas of adult rats. J Physiol Pharmacol 2008, 59(Suppl 4):87-102.
10. Kang Y., Xu L., Wang B., Chen A., Zheng G. Cutting edge: immunosuppressant as adjuvant for tolerogenic immunization. J Immunol 2008, 180:5172-5176.
11. Kono D.H., Urban J.L., Horvath S.J., Ando D.G., Saavedra R.A., Hood L. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J Exp Med 1988, 168:213-227.
12. La Flamme A.C., Ruddenklau K., Bäckström B.T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003, 71:4996-5004.
13. Li X.L., Lv J., Xi N.N., Wang T., Shang X.F., Xu H.Q., Han Z., O'Byrne K.T., Li X.F., Zheng R.Y. Neonatal endotoxin exposure suppresses experimental autoimmune encephalomyelitis through regulating the immune cells responsivity in the central nervous system of adult rats. Biochem Biophys Res Commun 2010, 398:302-308.
14. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmühl Y., Fischer D., Holsboer F., Wotjak C.T., Almeida O.F., Spengler D. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009, 12:1559-1566.
15. Okuda Y., Sakoda S., Fujimura H., Saeki Y., Kishimoto T., Yanagihara T. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J Neuroimmunol 1999, 101:188-196.
16. Pittock S.J., Weinshenker B.G., Noseworthy J.H., Lucchinetti C.F., Keegan M., Wingerchuk D.M., Carter J., Shuster E., Rodriguez M. Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol 2006, 63:611-614.
17. Pozzilli C., Marinelli F., Romano S., Bagnato F. Corticosteroids treatment. J Neurol Sci 2004, 223:47-51.
18. Ramagopalan S.V., Deluca G.C., Morrison K.M., Herrera B.M., Dyment D.A., Lincoln M.R., Orton S.M., Chao M.J., Degenhardt A., Pugliatti M., Sadovnick A.D., Sotgiu S., Ebers G.C. Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. J Neurol 2008, 255:1215-1219.
19. Reichardt H.M., Gold R., Lühder F. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Expert Rev Neurother 2006, 6:1657-1670.
20. Sewell D., Qing Z., Reinke E., Elliot D., Weinstock J., Sandor M., Fabry Z. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003, 15:59-69.
21. Shanks N., Larocque S., Meaney M.J. Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: early illness and later responsivity to stress. J Neurosci 1995, 15:376-384.
22. Shanks N., Windle R.J., Perks P.A., Harbuz M.S., Jessop D.S., Ingram C.D., Lightman S.L. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci U S A 2000, 97:5645-5650.
23. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
24. Sotgiu S., Pugliatti M., Fois M.L., Arru G., Sanna A., Sotgiu M.A., Rosati G. Genes, environment, and susceptibility to multiple sclerosis. Neurobiol Dis 2004, 17:131-143.
25. Thompson A.J., Toosy A.T., Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 2010, 9:1182-1199.
26. Tischner D., Reichardt H.M. Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol 2007, 275:62-70.
27. van den Brandt J., Voss K., Schott M., Hünig T., Wolfe M.S., Reichardt H.M. Inhibition of Notch signaling biases rat thymocyte development towards the NK cell lineage. Eur J Immunol 2004, 34:1405-1413.
28. Wang X.S., Chen Y.Y., Shang X.F., Zhu Z.G., Chen G.Q., Han Z., Shao B., Yang H.M., Xu H.Q., Chen J.F., Zheng R.Y. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis. Brain Res 2009, 1253:198-209.
29. Wang Y., McCusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol 2006, 118:143-151.
30. Wingerchuk D.M., Lucchinetti C.F., Noseworthy J.H. Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001, 81:263-281.
31. Zen M., Canova M., Campana C., Bettio S., Nalotto L., Rampudda M., Ramonda R., Iaccarino L., Doria A. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 2011, 10:305-310.